Diagnostics and Risk Stratification by Means of the Novel Marker CT-PROADM
Bergmann et al., US Patent 20,150,011,017 (2015) - PMID: n.a.
Product(s) used in this publication: Peptide Conjugates
Abstract:
Sorry, currently there is no abstract available.